3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
3
Gastrointestinal
2
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasms
1
Genetic Predisposition to Disease
1
Fanconi Anemia, Complementation Group D1
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
olaparib
5
stinging nettle lectin
1
peppermint oil
1
niraparib
1
liposomal doxorubicin
1
ferrous fumarate
1
apixaban
1
angiotensin I (1-7)
1
Tretinoin
1
Trabectedin
1
Surveys and Questionnaires
1
Rivaroxaban
1
Pharmacokinetics
1
Heparin, Low-Molecular-Weight
1
Genetic Counseling
1
Gemcitabine
1
Ferric Oxide, Saccharated
1
Epoetin Alfa
1
Demography
1
Data Collection
1
Darbepoetin alfa
1
Counseling
1
Cognitive Behavioral Therapy
1
Carboplatin
1
Aspirin
1
Anticoagulants
1
ALT-836
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Cognitive Behavioral Therapy
×
Classical hematology
×
Clear all
NCT03889171
2019-03-28
PSICOM
University Hospital, Montpellier
Completed
200 enrolled